CNSP
CNS PHARMA (CNSP)
NASDAQ
$4.92$0.00 (0.00%)
Price as of Jun 03, 2026 5:55 PM EDT
  • $8.0M
    Market Cap
  • -59.41%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
27,687
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
0
N/A
0
-100.00%
41,075
-90.69%
Gross Profit
0
N/A
0
-100.00%
27,687
+167.41%
-41,075
-90.69%
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-9.8M
+5.19%
-9.3M
-34.09%
-14.1M
+51.56%
-9.3M
-0.50%
Depreciation and Amortization Expense
3,918
+18.51%
3,306
-20.03%
4,134
-64.83%
11,756
-10.05%
Total Operating Expenses
16.0M
+7.28%
14.9M
-21.01%
18.9M
+23.57%
15.3M
+8.84%
Operating Profit
-16.0M
+7.28%
-14.9M
-21.01%
-18.9M
+23.57%
-15.3M
+8.84%
Interest Income
153,785
+155.19%
60,262
+117.65%
27,687
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
-13,805
+96.46%
-7,027
-24.32%
Interest Income and Expense and Net
153,785
+155.19%
60,262
+334.10%
13,882
+297.55%
-7,027
-105.77%
Total Nonoperating Income and Expense
135,995
+208.09%
44,142
+217.98%
13,882
+297.55%
-7,027
-24.32%
Income before Taxes
-16.0M
+7.28%
-14.9M
-21.01%
-18.9M
+23.57%
-15.3M
+8.84%
Income Taxes
0
N/A
0
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
N/A
N/A
N/A
N/A
-18.9M
+23.42%
-15.3M
+8.82%
Net Income from Continuing Operations Applicable to Common
N/A
N/A
N/A
N/A
-18.9M
+23.42%
-15.3M
+8.82%
Basic EPS and Net Income
-35.75
-8.03%
-38.87
+677.40%
-5.00
-55.44%
-11.22
+2,016.98%
Diluted EPS and Net Income
-35.75
-8.03%
-38.87
+677.40%
-5.00
-55.44%
-11.22
+2,016.98%
Basic Weighted Average Shares
443,369
+15.99%
382,241
-89.85%
3.8M
+176.66%
1.4M
-94.83%
Diluted Weighted Average Shares
443,369
+15.99%
382,241
-89.85%
3.8M
+176.66%
1.4M
-94.83%
Balance Sheet
Cash and Cash Equivalents
7.2M
+11.45%
6.5M
+1,077.53%
548,721
-94.54%
10.1M
+100.93%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
7.2M
+11.45%
6.5M
+1,077.53%
548,721
-94.54%
10.1M
+100.93%
Total Current Assets
8.1M
-6.42%
8.7M
+444.16%
1.6M
-87.34%
12.6M
+68.03%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
17,703
+194.80%
6,005
+21.73%
4,933
-12.91%
5,664
-64.84%
Total Long-Term Assets
520,665
+1,126.97%
42,435
-61.31%
109,683
-77.55%
488,470
-61.84%
Total Assets
8.6M
-0.89%
8.7M
+411.56%
1.7M
-86.97%
13.1M
+49.05%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
328,571
+0.77%
326,072
+8.40%
300,806
-26.63%
409,968
+5.72%
Total Current Liabilities
4.1M
+62.46%
2.5M
-58.84%
6.1M
+24.65%
4.9M
+130.40%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Liabilities
4.1M
+62.46%
2.5M
-58.84%
6.1M
+24.65%
4.9M
+130.40%
Retained Earnings
-100.3M
+18.77%
-84.4M
+21.36%
-69.6M
+37.17%
-50.7M
+44.97%
Total Stockholders Equity
4.5M
-26.78%
6.2M
+239.36%
-4.4M
-154.50%
8.1M
+22.82%
Total Shares Outstanding
632,516
-55.25%
1.4M
-77.25%
6.2M
+284.25%
1.6M
-94.21%
Cash Flow
Cash from Operating Activities
-13.8M
-19.30%
-17.1M
+21.03%
-14.1M
+33.93%
-10.6M
-22.02%
Capital Expenditures
18,175
+333.98%
4,188
+7.36%
3,901
-11.78%
4,422
N/A
Cash from Investing Activities
-18,175
+333.98%
-4,188
+7.36%
-3,901
-11.78%
-4,422
-23.07%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
14.6M
-36.74%
23.0M
+396.63%
4.6M
-70.30%
15.6M
+246.26%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
100.00%
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
-68,137.06%
N/A
N/A
N/A
Return on Assets
N/A
N/A
N/A
N/A
-255.54%
+82.45%
-140.06%
+22.79%
Return on Equity
N/A
N/A
N/A
N/A
-1,018.78%
+392.07%
-207.04%
+51.70%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
1.98
-42.39%
3.43
+1,222.28%
0.26
-89.84%
2.55
-27.07%
Cash Ratio
1.76
-31.40%
2.56
+2,759.89%
0.09
-95.62%
2.04
-12.79%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow